[ad_1] Activists protest the price of prescription drug costs in front of the U.S. Department of…
Tag: Eli Lilly and Co
Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
[ad_1] An Eli Lilly & Co. Zepbound injection pen, March 28, 2024. Bloomberg | Bloomberg |…
Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs
[ad_1] Zoom In IconArrows pointing outwards The direct-to-consumer health-care startup Ro launched a new free tool…
Eli Lilly blows past estimates, hikes guidance as Zepbound, Mounjaro sales soar
[ad_1] Eli Lilly on Thursday reported second-quarter earnings and revenue that blew past expectations and hiked…
Eli Lilly reports earnings Thursday. Here’s what Wall Street is watching
[ad_1] Investors want to know whether Eli Lilly is seeing the same pricing pressures on its…
Earnings playbook: Disney and this industrial giant are among companies slated to report this week
[ad_1] The second half of the earnings season is well under way, but a host of…
Wall Street will look for signs of what’s next for the market after a rocky start to August
[ad_1] Whether this is the correction investors have been waiting for could be made clear in…
Eli Lilly’s Zepbound and Mounjaro now available in U.S. after shortages, FDA says
[ad_1] An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York…
Eli Lilly’s weight loss drug Zepbound cuts heart failure risks in late-stage study
[ad_1] An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New…
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
[ad_1] Weight loss syringes of the brands “Wegovy”, “Ozempic” and “Mounjaro” are sold at In der…
GEHC gives reasons to look beyond temporary China woes and shares reverse higher
[ad_1] GE Healthcare on Wednesday morning reported a mixed second quarter and shares initially moved sharply…
Older GLP-1 drug from Novo Nordisk may slow Alzheimer’s disease progression by protecting the brain, study says
[ad_1] A box of the drug Victoza, made by Novo Nordisk Pharmaceutical, sits on a counter…
Here are JPMorgan’s top drug stock picks into earnings
[ad_1] JPMorgan is eyeing a few drug manufacturers ahead of their earnings reports as investors continue…
These drugmakers are catching up to Eli Lilly and Novo Nordisk in weight loss treatments
[ad_1] The lucrative market for weight loss drugs won’t stay a duopoly forever. With billions at…
European drug regulator rejects Alzheimer’s treatment Leqembi from Biogen, Eisai
[ad_1] European drug regulators on Friday rejected the Alzheimer’s treatment Leqembi from Biogen and Eisai, creating…